{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:34:10Z","timestamp":1787762050987,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Promoting quality of life (QoL) in patients with bronchiectasis, as a chronic disease, is a part of therapeutic principles. This study aimed to investigate QoL and its determinants in patients with noncystic fibrosis (CF) bronchiectasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study was conducted on 62 patients (38.7% male, mean age: 44) with non-CF bronchiectasis and involvement of \u22652 lobes in Qazvin, Iran. QoL was evaluated using the St. George's Respiratory Questionnaire (SGRQ). The relationships of QoL subscales with clinical (cough, dyspnea, and sputum volume) and paraclinical (spirometry, computerized tomography scan, sputum microbiology, and 6-min walk test [6-MWT]) were assessed using Pearson's correlation coefficient and multiple linear regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean SGRQ total score was 53.1 (standard deviation 19.8) out of 100. The level of dyspnea (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.543,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), cough (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.594,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), 6-MWT (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u22120.520,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), sputum volume (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.423,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002), and number of exacerbations (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.446,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009) had significant correlation with SGRQ total score. In multiple regression analysis, forced expiratory volume in 1 s was an independent predictor of the symptom (\u03b2 = \u22120.22,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.048) and activity (\u03b2 = \u22120.43,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03) subscales, whereas cough was an independent predictor of the symptom subscale (\u03b2 = \u22122.1,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In patients with non-CF bronchiectasis, the extent of lung impairment has a lower effect on the QoL than clinical symptoms. It seems that the QoL can be improved through the proper treatment of clinical symptoms and rehabilitation for promoting 6-MWT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jrms.jrms_665_20","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T01:41:22Z","timestamp":1690854082000},"page":"27","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Quality of life and its determinants in patients with noncystic fibrosis bronchiectasis"],"prefix":"10.4103","volume":"26","author":[{"given":"Ramin","family":"Sami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali","family":"Zohal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Khanali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Esmailzadehha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20240830","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-2600(18)30053-5","article-title":"Bronchiectasis: New therapies and new perspectives","volume":"6","author":"Chalmers","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R2-27-20240830","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/resp.13298","article-title":"Increased risk of acute coronary syndrome in patients with bronchiectasis: A population-based cohort study","volume":"23","author":"Hung","year":"2018","journal-title":"Respirology"},{"key":"R3-27-20240830","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/COPD.S132961","article-title":"Bronchiectasis in COPD patients: More than a comorbidity?","volume":"12","author":"Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R4-27-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2049-6958-7-3","article-title":"Extrapulmonary features of bronchiectasis: Muscle function, exercise capacity, fatigue, and health status","volume":"7","author":"Ozalp","year":"2012","journal-title":"Multidiscip Respir Med"},{"key":"R5-27-20240830","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fped.2017.00084","article-title":"Review: Quality of life in children with non-cystic fibrosis bronchiectasis","volume":"5","author":"Nathan","year":"2017","journal-title":"Front Pediatr"},{"key":"R6-27-20240830","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir Med"},{"key":"R7-27-20240830","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1378\/chest.128.2.739","article-title":"Quality-of-life determinants in patients with clinically stable bronchiectasis","volume":"128","author":"Mart\u00ednez-Garc\u00eda","year":"2005","journal-title":"Chest"},{"key":"R8-27-20240830","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"R9-27-20240830","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. George's Respiratory Questionnaire in bronchiectasis","volume":"156","author":"Wilson","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-27-20240830","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/1874306400903010107","article-title":"Measurement of the validity and reliability of the persian translation of the saint george respiratory questionnaire for patients with chronic obstructive pulmonary disease","volume":"3","author":"Fallah Tafti","year":"2009","journal-title":"Open Respir Med J"},{"key":"R11-27-20240830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert","year":"2004","journal-title":"Lancet"},{"key":"R12-27-20240830","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"R13-27-20240830","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0970-2113.45276","article-title":"How appropriate is the gold standard for diagnosis of airway obstruction?","volume":"25","author":"Aggarwal","year":"2008","journal-title":"Lung India"},{"key":"R14-27-20240830","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-27-20240830","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1183\/09031936.00150314","article-title":"An official European Respiratory Society\/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease","volume":"44","author":"Holland","year":"2014","journal-title":"Eur Respir J"},{"key":"R17-27-20240830","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"key":"R18-27-20240830","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.179.3.2027992","article-title":"Cystic fibrosis: Scoring system with thin-section CT","volume":"179","author":"Bhalla","year":"1991","journal-title":"Radiology"},{"key":"R19-27-20240830","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/13993003.00163-2016","article-title":"Phenotyping bronchiectasis: Is it all about sputum and infection?","volume":"47","author":"Smith","year":"2016","journal-title":"Eur Respir Soc"},{"key":"R20-27-20240830","first-page":"OA4951","article-title":"Determinants of quality of life in bronchiectasis using the quality of life bronchiectasis (QOL-B) questionnaire: data from the EMBARC registry","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur Respir J"},{"key":"R21-27-20240830","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1378\/chest.122.6.2030","article-title":"Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis","volume":"122","author":"Chan","year":"2002","journal-title":"Chest"},{"key":"R22-27-20240830","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2214\/ajr.173.1.10397099","article-title":"Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis","volume":"173","author":"Lynch","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"R23-27-20240830","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.rmed.2007.06.028","article-title":"Dissociation of lung function, dyspnea ratings and pulmonary extension in bronchiectasis","volume":"101","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Respir Med"},{"key":"R24-27-20240830","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/thorax.55.3.198","article-title":"Airflow obstruction in bronchiectasis: Correlation between computed tomography features and pulmonary function tests","volume":"55","author":"Roberts","year":"2000","journal-title":"Thorax"},{"key":"R25-27-20240830","first-page":"1602","article-title":"A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"R26-27-20240830","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12890-017-0544-x","article-title":"Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease","volume":"17","author":"Kamata","year":"2017","journal-title":"BMC Pulm Med"},{"key":"R27-27-20240830","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.rmed.2008.11.005","article-title":"Clinical determinants of the 6-Minute Walk Test in bronchiectasis","volume":"103","author":"Lee","year":"2009","journal-title":"Respir Med"},{"key":"R28-27-20240830","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/1471-2458-13-854","article-title":"Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States \u2013 National Health and Nutrition Examination Survey 2007-2010","volume":"13","author":"Wheaton","year":"2013","journal-title":"BMC Public Health"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.JRMS_665_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:17:09Z","timestamp":1787761029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.JRMS_665_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_665_20","relation":{},"ISSN":["1735-1995"],"issn-type":[{"value":"1735-1995","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}